NorthView Acquisition Corporation | SPAC Research

NorthView Acquisition Corporation

Status: Live Deal

U=S+W/2+R W=S@11.50 R=S/10

IPO Proceeds, $M	$189.75M
IPO Date	Dec 20, 2021
CEO	Jack Stover
Left Lead	I-Bankers Securities
IPO Cash in Trust	101.0%
SPAC Tenor	15 + 9 + 3 + 6 + 6
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	Profusa
Deal Announced	Nov 7, 2022
Deal Size, $M	$270.10M
Deal Sector	Healthcare
Deal Geography	US/Canada
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	Mar 21, 2025

NVAC NVACU NVACW NVACR

Price	$12.10
Last closing price	$12.10
H/L, today	$12.09 / $12.10
H/L, 52-week	$9.95 / $10.85
Volume, today	1
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.05
Last closing price	$0.05
High/low price, today	$0.05 / $0.05
High/low price, 52-week	$0.01 / $0.11
Volume, today	6
Volume, 3-month avg.	N/A

Price	$0.17
Last closing price	$0.17
High/low price, today	$0.17 / $0.17
High/low price, 52-week	$0.09 / $0.20
Volume, today	2
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.